Article Details

FDA Accepts RHHBY's sNDA for Gazyva in Treating Lupus Nephritis - Yahoo Finance

Retrieved on: 2025-03-05 18:00:35

Tags for this article:

Click the tags to see associated articles and topics

FDA Accepts RHHBY's sNDA for Gazyva in Treating Lupus Nephritis - Yahoo Finance. View article details on hiswai:

Excerpt

Roche's filing is based on data from a late-stage study that shows a complete renal response benefit in lupus nephritis patients who received ...

Article found on: au.finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo